Sara Geraci
Family · Anchorage, AKNPI 1962807891
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,542, 2.8 times the $543 reported in 2021. Among family clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 185 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$398
- Biogen$391
- EMD Serono, Inc.$371
- Lundbeck LLC$322
- Argenx US, Inc.$292
- Genentech USA, Inc.$237
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,141100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $398 |
| Biogen | 18 | $391 |
| EMD Serono, Inc. | 11 | $371 |
| Lundbeck LLC | 20 | $322 |
| Argenx US, Inc. | 10 | $292 |
| Genentech USA, Inc. | 15 | $237 |
| TG Therapeutics, Inc. | 10 | $225 |
| Eisai Inc. | 7 | $191 |
| Pfizer | 10 | $179 |
| UCB, Inc. | 6 | $176 |
| Neurelis, Inc. | 7 | $175 |
| Vanda Pharmaceuticals Inc. | 5 | $128 |
| Jazz Pharmaceuticals Inc. | 6 | $108 |
| Neurocrine Biosciences, Inc. | 6 | $96 |
| Teva Pharmaceuticals USA, Inc. | 4 | $91 |
| Amylyx Pharmaceuticals, Inc. | 4 | $82 |
| Sanofi | 4 | $80 |
| Merz Pharmaceuticals, LLC | 2 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
| Novartis | 3 | $59 |
| Amgen(2 entities) | 3 | $54 |
| ITF Therapeutics LLC | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $38 |
| Bristol Myers Squibb | 2 | $32 |
| TMS Neurohealth Centers Inc. | 1 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $23 |
| CSL Behring | 1 | $21 |
| Banner Life Sciences, LLC | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| GRT US Holding, Inc. | 1 | $19 |
| SK Life Science, Inc. | 1 | $18 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $13 |
How this compares
$4,141 in reported general payments places this provider in the 95th percentile of 315 family providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dalfampridine ErDalfampridine | 27 | $8,860 |
| Lamotrigine | 38 | $701 |
| Levetiracetam | 18 | $672 |
| Propranolol Hcl ErPropranolol Hcl | 11 | $632 |
| Duloxetine Hcl | 23 | $395 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 13 | $344 |
| Primidone | 14 | $295 |
| Sumatriptan Succinate | 14 | $276 |
| Baclofen | 13 | $271 |
| Memantine Hcl | 22 | $238 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $209 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $175 |
| Donepezil Hcl | 14 | $122 |
| Benztropine Mesylate | 22 | $120 |
| Clonazepam | 15 | $101 |
Paid to pharmacies, not to this prescriber.
Other family in Anchorage
- Erica HeagyAnchorage$249K
- Trisha KernodleAnchorage$60K
- Marisha DietersAnchorage$6K
- Christine HooverAnchorage$6K
- Leigh KeeferAnchorage$5K
- Christine SaganAnchorage$4K
- Bethany BuchananAnchorage$4K
- Natasha SherrillAnchorage$4K
- Katherine HardyAnchorage$3K
- Andrea BirchAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.